近半数报告症状可接受的轴性脊柱关节炎患者疾病活动度高
该横断面研究基于荷兰GLAS队列673例轴性脊柱关节炎患者,评估报告可接受症状状态(PASS)的比例及其与ASDAS的关系,并在SpA-Net队列159例中外部验证。结果显示77%患者报告PASS,但其中44%的ASDAS≥2.1;ASDAS预测PASS的AUC为0.84,最佳截断值为2.6。
要点
- 77%的axSpA患者报告PASS,但其中44%的ASDAS≥2.1,提示症状接受与疾病活动度不一致。
- 较低ASDAS、无附着点压痛及年龄较大与PASS独立相关(R²=0.39)。
- ASDAS预测PASS的AUC为0.84,最佳截断值2.6(敏感度78%,特异度77%)。
核心结论
- 在日常临床实践中,3/4的axSpA患者报告可接受的症状状态,但其中近半数疾病活动度高。
- ASDAS预测PASS的阈值为2.6,PASS问题可提供疾病活动度之外的额外信息,有助于共同决策。
研究设计与样本
- GLAS队列的横断面分析,纳入673例axSpA患者,并在SpA-Net队列159例患者中进行外部验证。
- 采用单变量和多变量逻辑回归识别PASS的决定因素,用AUC和最高Youden指数确定ASDAS预测PASS的准确性和阈值。
主要发现
- GLAS队列中63%为男性,平均年龄48(±14)岁,平均ASDAS 2.3(±0.9);77%患者报告PASS,其中44%的ASDAS≥2.1。
- 多变量回归显示较低ASDAS、无附着点压痛和年龄较大与报告PASS独立相关(R²=0.39)。
- ASDAS预测PASS的AUC为0.84(95%CI 0.80-0.85),最佳截断值2.6(敏感度78%,特异度77%);SpA-Net队列结果相似。
关键数值与推荐
- ASDAS预测PASS的最佳截断值为2.6,敏感度78%,特异度77%,AUC 0.84(95%CI 0.80-0.85)。
- 报告PASS的患者中44%的ASDAS≥2.1,提示高疾病活动度。
临床怎么用
- 临床中应结合PASS提问与ASDAS评估,避免仅凭症状接受状态低估疾病活动度。
- ASDAS阈值2.6可作为预测PASS的参考,辅助共同决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the proportion of axial spondylarthritis (axSpA) patients reporting PASS, explore variables associated with PASS and determine the relation with axSpA Disease Activity Score (ASDAS) to predict PASS in two Dutch standard-of-care cohorts. METHODS: Patients from the GLAS cohort were included in this cross-sectional analysis. External validation was performed in the SpA-Net cohort. Univariable and multivariable logistic regression were performed to identify determinants of PASS. The predictive accuracy and threshold of the ASDAS for predicting PASS were determined using AUC and highest Youden's index. RESULTS: Of 673 included GLAS patients, 63 % were male, mean age was 48 (±14) years, and mean ASDAS 2.3 (±0.9). In total, 77 % perceived their symptom state as acceptable. Of these patients, 44 % had an ASDAS ≥2.1. In multivariable regression, lower ASDAS, absence of tender entheses and older age were independently associated with reported PASS (R² = 0.39). The ASDAS showed good accuracy in predicting PASS, with AUC of 0.84 (95 % CI 0.80-0.85) and optimal cut-off value of 2.6 (sensitivity 78 %, specificity 77 %). Similar results were found in the 159 patients from SpA-Net. CONCLUSION: In daily clinical practice, 3 out of 4 axSpA patients report an acceptable symptom state, although almost half of them have high disease activity. In line, the ASDAS threshold for predicting PASS is 2.6. Our results show that the PASS question provides additional information to disease activity, which can contribute to better shared decision making.
引用
- Carbo M, Kampman A, Paap D, et al. Almost half of the patients with axial spondyloarthritis reporting an acceptable symptom state have high disease activity; data from two standard-of-care cohorts. Semin Arthritis Rheum. 2025. PMID: 41483750. doi:10.1016/j.semarthrit.2025.152903
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。